Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Advanced Gastric Cancer
NCT00519324Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in gastric adenocarcinoma, sponsored by Novartis. Started Aug 2007; status: completed.
02
Drugs
everolimus
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00519324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519324.